EA202092327A1 - LFA3 OPTIONS AND THEIR COMPOSITIONS AND APPLICATIONS - Google Patents

LFA3 OPTIONS AND THEIR COMPOSITIONS AND APPLICATIONS

Info

Publication number
EA202092327A1
EA202092327A1 EA202092327A EA202092327A EA202092327A1 EA 202092327 A1 EA202092327 A1 EA 202092327A1 EA 202092327 A EA202092327 A EA 202092327A EA 202092327 A EA202092327 A EA 202092327A EA 202092327 A1 EA202092327 A1 EA 202092327A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lfa3
options
compositions
applications
polypeptide molecules
Prior art date
Application number
EA202092327A
Other languages
Russian (ru)
Inventor
Наташа Кей Креллин
Лорен Кейт Эли
Джейсон Роблес Рейес
Тиа Ти Хо
Джеффри Э. Блюстоун
Элеонора Тротта
Цичжи Тан
Original Assignee
Пфайзер Инк.
Те Риджентс Оф Те Юниверсити Оф Калифорния
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк., Те Риджентс Оф Те Юниверсити Оф Калифорния filed Critical Пфайзер Инк.
Priority claimed from PCT/US2019/023883 external-priority patent/WO2019190984A1/en
Publication of EA202092327A1 publication Critical patent/EA202092327A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к молекулам полипептида LFA3, например вариантным молекулам гибридного полипептида LFA3. Изобретение включает применение и ассоциированные способы применения молекул полипептида LFA3.The invention relates to LFA3 polypeptide molecules, eg, variant LFA3 fusion polypeptide molecules. The invention includes the use and associated methods of using LFA3 polypeptide molecules.

EA202092327A 2018-12-21 2019-03-25 LFA3 OPTIONS AND THEIR COMPOSITIONS AND APPLICATIONS EA202092327A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862783986P 2018-12-21 2018-12-21
PCT/US2019/023883 WO2019190984A1 (en) 2018-03-29 2019-03-25 Lfa3 variants and compositions and uses thereof

Publications (1)

Publication Number Publication Date
EA202092327A1 true EA202092327A1 (en) 2021-03-10

Family

ID=75262222

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092327A EA202092327A1 (en) 2018-12-21 2019-03-25 LFA3 OPTIONS AND THEIR COMPOSITIONS AND APPLICATIONS

Country Status (1)

Country Link
EA (1) EA202092327A1 (en)

Similar Documents

Publication Publication Date Title
EA202091898A1 (en) ANTIBODIES THAT NEUTRALIZE THE HUMAN IMMUNODEFICIENCY VIRUS
EA201891083A1 (en) COMPOSITIONS OF ANTIBODIES TO CD38 FOR SCRAPTURE AND THEIR APPLICATION
CY1124806T1 (en) ENANTI-CD40 ANTIBODIES AND USES THEREOF
EA201792500A1 (en) AAV-MEDIATED EXPRESSION OF ANTIBODIES AGAINST FLU AND METHODS OF THEIR USE
EA201791562A1 (en) CYTOMEGALOVIRUS ANTIGENS AND THEIR APPLICATIONS
EA201890423A1 (en) SLIGHT PROTEINS OF THE FACTOR IX, METHODS OF THEIR RECEPTION AND APPLICATION
EA202190609A1 (en) ANTIBODIES AGAINST HLA-G, COMPOSITIONS CONTAINING ANTIBODIES AGAINST HLA-G, AND METHODS OF APPLICATION ANTIBODIES AGAINST HLA-G
MX2020010951A (en) Anti-hla-g antibodies and use thereof.
EA202090296A1 (en) SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PREPARATION AND APPLICATION
EA202092692A1 (en) ANALOGUES OF RAPAMICIN AND THEIR APPLICATIONS
EA201791500A1 (en) CYCLOPROPANKARCARBOXAMID MODULATORS OF THE MUCOVISCIDOUS TRANSMEMBRANE CONDUCTOR REGULATOR
MX2020007628A (en) Compositions and methods of use.
CY1124727T1 (en) TATK-CDKL5 FUSION PROTEINS, COMPOSITIONS, PHARMACEUTICAL FORMS AND THEIR USE
EA202090312A1 (en) SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PREPARATION AND APPLICATION
PH12021550705A1 (en) Stable semaglutide compositions and uses thereof
EA201792262A1 (en) PIROGLUTAMAT VORTIOKSETINA
EA202090084A1 (en) NEW THERAPEUTIC ENZYME Fusion PROTEIN AND ITS APPLICATION
BR112016025450A2 (en) ion channel modulators and uses thereof
EA202192146A1 (en) ANTIBODIES FOR CLAUDIN 6 AND THEIR APPLICATION
EA202091567A1 (en) CHIMERIC PROTEINS MIT
EA201591421A1 (en) DRUGS OF POLYPEPTIDE FACTOR IX
CL2019003167A1 (en) Anti-jagged1 antigen-binding proteins.
EA202092909A1 (en) NEW BENZODIAZEPINE, ITS DERIVATIVES AND APPLICATIONS
EA202191403A1 (en) COMPOSITION WITH HIGH PROTEIN CONCENTRATION
EA202092335A1 (en) COMPOSITIONS BASED ON ERENUMAB AND WAYS OF THEIR APPLICATION